Clinical trials recruiting for Anti-PD-1 Antibody
3
Recruiting trials
0
US states with sites
1
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 1 1Phase 2 3
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Anti-PD-1 antibody | 2 |
| NAs | 2 |
| Peg-IFNα | 1 |
| Sintilimab | 1 |
| hypofractionated radiotherapy | 1 |
Self-screener
Recruiting trials
- A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (A)
- A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (B)
- Sintilimab Plus Hypofractionated Radiotherapy for MSI-H/dMMR Rectal Cancer
Related conditions
Trials recruiting for Anti-PD-1 Antibody often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Anti-PD-1 Antibody trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.